Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

OptiNose, Inc. - Common Stock (NQ:OPTN)

9.140 -0.030 (-0.33%)
Streaming Delayed Price Updated: 3:05 PM EDT, Apr 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about OptiNose, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
OptiNose: Q1 Earnings Insights
OptiNose (NASDAQ:OPTN) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
OptiNose Earnings Preview
OptiNose (NASDAQ:OPTN) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that OptiNose will... 
Via Benzinga
OptiNose's Return On Capital Employed Insights
According to data from Benzinga Pro, during Q4, OptiNose's (NASDAQ:OPTN) reported sales totaled $22.51 million. Despite a 8.72% increase in earnings, the company posted a loss of... 
Via Benzinga
Optinose's XHANCE Meets Primary Endpoints In Chronic Sinusitis Trial
Optinose Inc (NASDAQ: OPTN) has announced positive data from the ReOpen1 Phase 3 trial of Xhance (fluticasone propionate) Exhalation Delivery System in chronic... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers OptiNose (NASDAQ:OPTN) shares mov... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers ACADIA Pharmaceuticals (NASDAQ:ACAD 
Via Benzinga
OptiNose: Q2 Earnings Insights
Shares of OptiNose (NASDAQ:OPTN) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share were up 21.43% year over year to ($0.44),... 
Via Benzinga
Earnings Scheduled For May 12, 2022
Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter. 
Via Benzinga
OptiNose: Q4 Earnings Insights
OptiNose (NASDAQ:OPTN) reported its Q4 earnings results on Tuesday, March 8, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
Earnings Preview: OptiNose
OptiNose (NASDAQ:OPTN) is set to give its latest quarterly earnings report on Tuesday, 2022-03-08. Here's what investors need to know before the announcement. Analysts estimate... 
Via Benzinga
Earnings Scheduled For March 8, 2022
Companies Reporting Before The Bell • Babcock & Wilcox (NYSE:BW) is likely to report quarterly earnings at $0.10 per share on revenue of $196.62 million. •... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers EyePoint Pharmaceuticals (NASDAQ:EYP... 
Via Benzinga
80 Biggest Movers From Yesterday
Gainers BIMI International Medical Inc. (NASDAQ: BIMI) shares surged 55% to close at $1.00 on Tuesday as the company reported a narrower Q3 loss. Progenity, Inc. (NASDAQ: PROG)... 
Via Benzinga
Mid-Afternoon Market Update: Dow Jumps 150 Points; Talkspace Shares Slide
Toward the end of trading Tuesday, the Dow traded up 0.42% to 36,239.46 while the NASDAQ rose 0.76% to 15,974.21. The S&P also rose, gaining 0.59% to 4,710.24. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
Mid-Day Market Update: Crude Oil Down 1%; Kezar Life Sciences Shares Surge
Midway through trading Tuesday, the Dow traded up 0.25% to 36,176.74 while the NASDAQ rose 0.19% to 15,883.75. The S&P also rose, gaining 0.21% to 4,692.49. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Mid-Morning Market Update: Markets Open Higher; Walmart Tops Q3 Expectations
Following the market opening Tuesday, the Dow traded up 0.40% to 36,231.05 while the NASDAQ rose 0.20% to 15,885.76. The S&P also rose, gaining 0.31% to 4,697.11. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Kezar Life Sciences (NASDAQ:KZR) stock rose 48.27% to $12.47 during Tuesday's pre-market session. The market value of their outstanding shares is at $612.8... 
Via Benzinga
53 Stocks Moving In Tuesday's Mid-Day Session
Gainers BIMI International Medical Inc. (NASDAQ: BIMI) jumped 65.7% to $1.0691 as the company reported a narrower Q3 loss. Progenity, Inc. (NASDAQ: PROG) shares climbed 35.5% to... 
Via Benzinga
The Daily Biotech Pulse: Kezar Jumps On Data, Biogen R&D Chief To Retire, Molecular Partners Wilts On COVID Trial Disappointment
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Kezar Life Sciences Reports Positive Interim Phase 2 Data For Lupus Nephritis... 
Via Benzinga
See Why Optinose Shares Plunged To 52-Week Low Today
ENT and allergy-focused company Optinose Inc (NASDAQ: OPTN) posted Q3 Xhance (fluticasone propionate) sales of $21.8 million, +41% Y/Y, missing the consensus of $23.48... 
Via Benzinga
The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More
Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at... 
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers OptiNose (NASDAQ:OPTN) stock rose 17.74% to $3.11 during Friday's pre-market session. The company's market cap stands at $165.7 million. DBV Technologies (... 
Via Benzinga
Earnings Scheduled For November 15, 2021
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its third quarter. • Tyson Foods (NYSE:TSN) is estimated to... 
Via Benzinga
How Good Are OptiNose's Earnings? | Return On Capital Employed
According to Benzinga Pro data, during Q2, OptiNose (NASDAQ:OPTN) posted sales of $18.36 million. Earnings were up 11.87%, but OptiNose still reported an overall loss of $19.55... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Syndax Pharmaceuticals (NASDAQ:SNDX) shares moved upwards by 8.94% to $20.48 during Monday's pre-market session. The company's market cap stands at $995.9... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Cellectar Biosciences (NASDAQ:CLRB 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday morning, 67 companies achieved new lows for the year. Areas of Significance: Grifols (NASDAQ:GRFS) was the largest firm by market cap to set a new 52-... 
Via Benzinga
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (... 
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,... 
Via Benzinga
Exposures Product Safety
Earnings Scheduled For August 11, 2021
Companies Reporting Before The Bell • Wireless Telecom Group (AMEX:WTT) is likely to report earnings for its second quarter. • Gamida Cell (NASDAQ:GMDA) is... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.